Senior insider sale
Chief Financial Officer at MEREO BIOPHARMA GROUP PLC — senior position signals high conviction
$279.7K
70.72K shares
What this filing means
FOX CHRISTINE ANN plans to sell 70.72K shares of MEREO BIOPHARMA GROUP PLC valued at approximately $279.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/12/2024ACC: 0000950170-24-105902
Officer· Chief Financial Officer
Since Feb 2026
70.72K
Shares to sell
$279.7K
Approx. market value
60K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Same Day Cashless Exercise and Sale
Equity Compensation
9/12/2024
60KTotal acquired60K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/12/2024 | Same Day Cashless Exercise and Sale Equity Compensation | 60K | — |
| Total | 60K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
29.44K
Market value
$99.9K
6/26/2024
—Completed
Units to sell
12.99K
Market value
$48.0K
6/25/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
28.29K
Market value
$131.8K
9/12/2024
Total
Units
70.72K
Value
$279.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/26/2024 | 29.44K | $99.9K | — | Completed |
6/25/2024 | 12.99K | $48.0K | — | Completed |
| Planned — Approximate Date | ||||
9/12/2024 | 28.29K | $131.8K | NASDAQ | Planned |
| Total | 70.72K | $279.7K | ||